Common questions about our model, how we work with companies, and what makes us different.
Learn MoreFrom Pre-IND to NDA and everything in between, RRD has a proven track record of successful client engagements.
Learn More
Investor Partnerships
RRD International's investor alliances provide an unparalleled breadth and depth of clinical development and regulatory resources to a biopharmaceutical company’s pipeline. On behalf of these partners, RRD manages and designs global and domestic clinical development programs in collaboration with biopharmaceutical companies with an eye towards regulatory approval.
As needed, RRD can manage all aspects of product development including clinical, preclinical, regulatory/quality systems and manufacturing. RRD’s far-reaching networks of clinical, technical and regulatory experts contribute broad expertise across all therapeutic areas and classes of drugs.
Symphony Capital
Symphony Capital collaborates with leading innovative biopharmaceutical companies to invest in their strategically important clinical development programs, enabling companies to fully fund robust clinical trials, accelerate the development of their product pipelines, and create more value for their shareholders.
The Symphony Capital team brings more than two decades of strategic, financial, clinical and regulatory experience within the biopharmaceutical industry to our portfolio companies’ pipelines. Symphony’s experience in financing and advising many of the world’s leading biotechnology companies extends back to the earliest days of the industry.